A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at home.

Koichi Hirata,Takao Takeshima,Noboru Imai,Hisaka Igarashi, Masako Shiosakai, Masanobu Inage, Fumi Sakurai,Xiaoping Ning,Masami Nakai,Nobuyuki Koga

Expert opinion on drug safety（2022）

引用 0|浏览3

暂无评分

摘要

Overall, AI-assisted, at-home self-injection of fremanezumab was found to be generally safe and well-tolerated. This injection strategy is considered clinically meaningful in view of improved utility of and adherence to the drug.

查看译文

关键词

Auto-injection device,fremanezumab,migraine,safety evaluation,utility

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要